Details for 2015782866
Up to date per 01.04.2026
Actions
Details for 2015782866
Granted/Registered
European Patent
01.03.2017 A
11.08.2021 B1
23.04.2014
US
201461983003 P
A23J 1/08 20060101AFI20201215BHEP
Owner
Alexion Pharmaceuticals, Inc.100 College Street New Haven, CT 06510US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
CHEN, Liang7917 Jake View Lane San Diego, CA 92129US
LEAVITT, Markley C.1140 Latham Drive Watkinsville, GA 30677US
TITUS, Michael33 Hayden Ave. Lexington, MA 02421US
Information about Fees